GABRIEL STEG

 

Dr. Steg has been a Professor of Cardiology at the Université Paris - Diderot, Sorbonne-Paris Cité, since 1994. He is also Professor at the National Heart and Lung Institute, Imperial College, London, UK since 2013. He works as an interventional cardiologist and is Director of the Coronary Care Unit of Hôpital Bichat, a large academic institution affiliated with Assistance Publique-Hôpitaux de Paris, in Paris, France. He is also Director of the “Clinical Research in Atherothrombosis” Research Team, created in 2008 at INSERM U-698, Hôpital Bichat, Paris and a co-coordinator of the Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation and REmodeling) affiliated with INSERM, Université Paris Diderot and Assistance Publique – Hôpitaux de Paris. He is chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research organization, which is a member of the VIGOUR collaboration.

Dr Steg’s research interests are in the field of coronary artery disease. He is involved in studies of intervention in acute coronary syndromes, but has also turned his attention to the epidemiology of atherothrombosis and atrial fibrillation. He is a former member of the Board of the French Society of Cardiology. He is an honorary member of the Institut Universitaire de France, a fellow of the European Society of Cardiology, and American College of Cardiology. He received the silver medal of the European Society of Cardiology in 2011. Dr Steg is currently chairing or co-chairing several large clinical trials or registries, such as REACH, TAO, EURIKA, EUROMAX, REALISE-AF, ODYSSEY-CV Outcomes, VIVIFY, CLARIFY, and THEMIS. He also participates in the leadership of many trials in coronary artery disease, such as PLATO, SIGNIFY, PROTECT, SAVOR-TIMI53, CHAMPION-Phoenix, DAPT, STABILITY, SOLID-TIMI52 and PEGASUS. He is co-chair of the GRACE registry publication committee. He was DSMB or CEC member or chair for several large trials. Dr Steg has authored more than 600 articles in peer-reviewed international journals, and is a member of the editorial board for Circulation, Circulation: Cardiovascular Interventions, and the European Heart Journal, He is the Editor-in-Chief of the french edition of Theheart.org and Editor-in-Chief for Medscape France. Finally, Dr Steg was co-chair of the ESC task force in charge of the 2012 Guidelines for management of ST-segment elevation myocardial infarction.

74dnxcx6